The Inflation Reduction Act’s Effects on the Life Sciences Industry
Our industry experts break down the IRA’s impact on life sciences, highlighting critical shifts in drug pricing strategy, R&D allocation, and commercialization models.
Litigating the Mitigating Factors
John Asker of the University of California, Los Angeles participated in this webinar panel hosted by the American Bar Association.
FTC Roundtable Discussion on the Creative Economy and Generative AI
The authors provide an overview of the key issues raised by the roundtable’s participants.
The George Washington University Competition Law Center and Crowell & Moring’s Fifth Annual Antitrust and Tech Conference
Joanna Tsai will participate in a panel titled “Looking Forward: What’s Ahead for Antitrust in 2024?” at this Washington, DC event.
Innovation in Merger Control
This article discusses the considerations for forward looking economic analysis of dynamic innovation and R&D effects in mergers.
GAR Academy Damages in International Arbitration
Ronnie Barnes serves as a faculty member in GAR Academy’s Damages in International Arbitration Massive Open Online Course (MOOC).
Cross-Market Implications in FTC’s Anesthesia Complaint
The authors discuss how precedents from this case could potentially provide a framework under which the FTC will challenge mergers.
Dublin International Arbitration Day 2023
Ronnie Barnes will moderate a panel titled, ‘Arbitration, Bankruptcy & Sanctions,’ at this annual conference in Ireland.
Resale Price Maintenance & the Digital Age
Nathaniel Hipsman will moderate a panel of practitioners, economists, and government enforcement officials at this American Bar Association event.
The Global Antitrust Economics Conference 2023
Rainer Schwabe and Anand Krishnamurthy will join competition experts to discuss the role of financial services and life sciences in antitrust.
FTC v. US Anesthesia Partners: Serial Acquisitions and Private Equity in Focus
Laurien Gilbert and Michael Richards of Cornell University will discuss the role of private equity firms in healthcare at this ABA event.
SEC Enforcement Actions Against Public Companies and Subsidiaries Jump in FY 2023
Total monetary value of settlements fell to lowest level in last eight fiscal years.
How can we help you?
If you are looking for a publication not on our website, contact us.